Getting my steps on the #MLK #FreedomTrail in #Atlanta in before American College of Cardiology #acc24 day 2! #hearthealth #running

So proud of Ben Stark for presenting our research on Institute for Health Metrics and Evaluation (IHME) #GBD of #heartdisease in US
American College of Cardiology #ACC24

It has been a great honor to serve as chair of the American College of Cardiology #CVPrev section for the past 3 years. Special thanks to Kim Kooi for supporting me. I know I am leaving the section in great hands Eugenia Gianos MD

Great to see old UMN Medical School friends American College of Cardiology #ACC24 Christina Thaler

Congratulations ADAPTABLE Study team!
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic #CVD JAHA Schuyler Jones Adrian “WE NEED RCTS!” Hernandez Guillaume Marquis-Gravel
ahajournals.org/doi/10.1161/JA…

Baseline use of P2Y12 inhibitors (clopidogrel, prasugrel) does not appear to modify the effectiveness and safety of high vs. low-dose aspirin for secondary prevention of #ASCVD . Saket Girotra Katie Benziger MD MPH Matthew Roe Robert Harrington Schuyler Jones JAHA bit.ly/400J1B9

Watch me on TV!
Wegovy could reduce #heartattack and #stroke risk kfyrtv.com/2023/11/15/weg… EssentiaHealth

I'm proud of academic medicine's commitment to strengthening health care access in rural and underserved areas! #PowerofRural #StartsinAcademicMedicine AAMC EssentiaHealth

Q5) What causes high Lpa ( #knowLpa ) and does it run in families?
A5) Your genes cause high Lpa. High Lpa definitely runs in families! If a relative has high Lpa there is a good chance you do too! Learn more Family Heart Foundation

A5:
🧬Lp(a) is genetically determined- meaning you inherited it from your parents
🧬 #Knowlpa is ⤴️ is the first step to ensuring you lower your risk for heart disease.
🧬You can't change your genes (yet) or choose your parents, but you can change your risk
#runsinthefamily

Time to go back home and share all the #AHA23 science (and new pins) with my colleagues EssentiaHealth!
Exciting time to be a #cardiologist
#obesity
#diabetes
#hypertension #lipids #cvd
AHAMeetings see you in Chicago in 2024!

Lepodisiran, an siRNA targeting LPA, enters the Lp(a)-lowering ring with an impressive 94% lowering of Lp(a) at 48w after a single inj in ph1 dose-escalation study among individuals with median Lp(a) 113 nmol/L.
Efficacy is on par with the other 2 LPA-targeting siRNAs (olpasiran

I'm thrilled to announce world-renowned women’s health researcher, Dr. Carolyn Mazure, as the chair of the first-ever White House Initiative on Women’s Health Research.

Alongside the Gender Policy Council, she will lead our effort to improve the health and lives of women across

Exciting news for women's health! President Biden is taking a groundbreaking step by establishing a White House Initiative on Women’s Health Research, led by Jill Biden and chaired by Dr. Carolyn Mazure. whitehouse.gov/briefing-room/….

I'm proud to establish a new White House Initiative on Women’s Health Research, an effort led by the First Lady and my Gender Policy Council.

Together, they'll work to ensure our Administration does everything it can to drive innovation in women’s health and close research gaps.

Calling all #cardiologists , CV #surgeons , PhDs (who completed training by 2023):
✅join American College of Cardiology
✅apply for clinical trials training program
NEW: valve/structural
You won't regret it!
acc.org/CTR2024
AHAMeetings Pamela S Douglas Tracy Wang Minnow Walsh, MD, MACC

Original Article: Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia (MINT trial) nej.md/49rFHDG

#AHA23 AHA Science

Excellent talk by Nicholas Hendren Parkland Health about an innovative home inotrope program for unfunded patients with a variety of HF eitiologies #aha23 AHAMeetings Steve Bradley

Original Article: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation nej.md/3sqCbJ1

Editorial: What Lies beneath the Surface — Treatment of Subclinical Atrial Fibrillation nej.md/47o4k22

#AHA23 AHA Science

Wow. Unmeasurable levels of Lp(a) up to 9 months with single dose of Eli Lilly and Company’s lepodisiran (up to -94% out to almost a year). #AHA2023